Last update 08 Nov 2025

Acetaminophen/Diphenhydramine Hydrochloride/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Guaifenesin/Riboflavin/Ascorbic Acid/Glycine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
PANTEC TIME, 판텍타임건조시럽
Target
H1 receptor x σ1 receptor
Action
antagonists, agonists, modulators
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists), σ1 receptor agonists(Sigma opioid receptor agonists), Amino acid modulators
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Common Cold
Inactive Indication-
Originator Organization
Dong-A Pharmaceutical Co., Ltd.Dong-A Pharmaceutical Co., Ltd.
Active Organization
Dong-A Pharmaceutical Co., Ltd.Dong-A Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (31 Jul 2025),
Common Cold
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC17H20N4O6
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N
CAS Registry83-88-5
View All Structures (12)

Related

100 Clinical Results associated with Acetaminophen/Diphenhydramine Hydrochloride/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Guaifenesin/Riboflavin/Ascorbic Acid/Glycine
Login to view more data
100 Translational Medicine associated with Acetaminophen/Diphenhydramine Hydrochloride/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Guaifenesin/Riboflavin/Ascorbic Acid/Glycine
Login to view more data
100 Patents (Medical) associated with Acetaminophen/Diphenhydramine Hydrochloride/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Guaifenesin/Riboflavin/Ascorbic Acid/Glycine
Login to view more data
100 Deals associated with Acetaminophen/Diphenhydramine Hydrochloride/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide Hydrate/DL-Methylephedrine Hydrochloride/Guaifenesin/Riboflavin/Ascorbic Acid/Glycine
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Common Cold
South Korea
Dong-A Pharmaceutical Co., Ltd.Dong-A Pharmaceutical Co., Ltd.
31 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free